Home/ Supplements/ Inositol/ Regulate

Regulate

product on market Capsule Eu Natural Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Myo-inositol and D-chiro-inositol are researched for their role in supporting insulin sensitivity and hormonal balance. There is moderate evidence suggesting these compounds can help regulate metabolic functions and reproductive health. The ingredient profile maintains a high safety rating based on available data.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Regulate
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Vegetarian Capsule(s)
Serving Size
45
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1000 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)

Other Ingredients

Cellulose
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use 2 capsules twice daily with a meal and 8 oz. H2O

Warnings & Precautions

Caution: Keep out of reach of children.

If you are pregnant, nursing, or taking any prescription medicine, consult your physician before taking this product.

Formulation Notes

Taken to promote hormonal balance, REGULATE provides Myo-Inositol and D-Chiro Inositol in a 40:1 ratio to support your ovarian system.

Zero fillers / binder Artificial ingredients

Myo & D-Chiro Inositol

Ovarian & hormones natural balance

Zero fillers, zero binders, zero artificial ingredients Gluten, wheat & dairy free

Additional Information

Plant-powered multi-blend for "Eu" (you)!

CGMP Certified Blended in the USA

Share your story #EuNatural #BeYou

Metadata

Product Details

UPC / SKU8 55244 00831 8
DSLD Entry Date2025-01-23
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID321861
Data Updated2026-04-11
Research

Research Evidence

32
Research Sources
50
Avg Quality
19
Rct
7
Meta Analysis
3
Clinical Trial
2
Other
1
Systematic Review
B Greater Choline-Containing Compounds and Myo-inositol in Treatment-Resistant Versus Responsive Schizophrenia: A 1H-Magnetic Resonance Spectroscopy Meta-analysis
Meta Analysis Biological psychiatry. Cognitive neuroscience and neuroimaging 2024 PubMed DOI
B Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines
Meta Analysis The Journal of clinical endocrinology and metabolism 2024 PubMed DOI
B Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes
Meta Analysis The Cochrane database of systematic reviews 2023 PubMed DOI
B Effectiveness of inositol, metformin and their combination in women with PCOS undergoing assisted reproduction: systematic review and meta-analysis
Meta Analysis Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2022 PubMed DOI
B Effects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis
Meta Analysis Irish journal of medical science 2023 PubMed DOI
B Inositol for subfertile women with polycystic ovary syndrome
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
B Treatment of lean PCOS teenagers: a follow-up comparison between Myo-Inositol and oral contraceptives
Rct European review for medical and pharmacological sciences 2021 PubMed DOI
B The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios
Rct European review for medical and pharmacological sciences 2019 PubMed DOI
C Investigating the effect of combined use of selenium and Myo-inositol supplements on thyroid function and autoimmune characteristics in thyroid disorders: a systematic review and meta-analysis
Meta Analysis Expert review of endocrinology & metabolism 2024 PubMed DOI
C Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial.
Rct International journal of food sciences and nutrition PubMed DOI
View all evidence for Inositol →
Compare

Similar Products

View all Inositol products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.